Kalász H, Tekes K, Faigl EB, Pöstényi Z, Berekméri E, Karvaly G, Adeghate E. Monitoring the Level of
14C-Labelled Selegiline Following Oral Administration.
THE OPEN MEDICINAL CHEMISTRY JOURNAL 2017;
11:1-8. [PMID:
28567124 PMCID:
PMC5418945 DOI:
10.2174/1874104501711010001]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Revised: 11/29/2016] [Accepted: 11/30/2016] [Indexed: 11/23/2022]
Abstract
Background:
Selegiline [(-)-deprenyl] is widely used for the treatment of Parkinson’s disease in humans.
Objective:
Time-dependence of tissue distribution of selegiline following per os administration to rats.
Method:
Oral administration of radiolabeled selegiline to rats resulted in a pattern of tissue distribution similar to that following intraperitoneal injection. Analyses were done using both reversed-phase HPLC and also by counting radioactivity in various body compartments of rats.
Results:
As a consequence of oral administration of 30 mg/kg of selegiline, its level in the stomach was extremely high (179.57 µg/g tissue through 54.67 µg/g at 15 min to 120 min), that is one magnitude higher than that in the serum level. High selegiline concentrations were also detected in the lacrimal glands (7.45 µg/g), kidneys (6.87 µg/g), livers (6.01 µg/g) and lungs (3.47 µg/g) after 30 minutes of application, which were higher than after intraperitoneal injections.
Conclusion:
The relatively high tissue levels remained for 120 min monitoring. Selegiline levels in the brain (1.69 µg/g) and in the testes (1.88 µg/g) were also considerably higher than following intraperitoneal administration during the entire period of observation (15 to 120 min).
Collapse